134 related articles for article (PubMed ID: 3926467)
1. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
Judd AM; Login IS; Kovacs K; Ross PC; Spangelo BL; Jarvis WD; MacLeod RM
Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508
[TBL] [Abstract][Full Text] [Related]
3. Dopamine inhibits calcium flux in the 7315a prolactin-secreting pituitary tumour.
Login IS; Judd AM; Macleod RM
Cell Calcium; 1988 Feb; 9(1):27-31. PubMed ID: 3359479
[TBL] [Abstract][Full Text] [Related]
4. Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
Koike K; Judd AM; Login IS; Yasumoto T; MacLeod RM
Neuroendocrinology; 1986; 43(3):283-90. PubMed ID: 2426623
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
Schettini G; Cronin MJ; MacLeod RM
Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
[TBL] [Abstract][Full Text] [Related]
6. Reserpine is a calcium channel antagonist in normal and GH3 rat pituitary cells.
Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
Am J Physiol; 1985 Jan; 248(1 Pt 1):E15-9. PubMed ID: 2578255
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1-beta modulation of prolactin secretion from rat anterior pituitary cells: involvement of adenylate cyclase activity and calcium mobilization.
Schettini G; Florio T; Meucci O; Landolfi E; Grimaldi M; Lombardi G; Scala G; Leong D
Endocrinology; 1990 Mar; 126(3):1435-41. PubMed ID: 2407518
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic inhibition of anterior pituitary adenylate cyclase activity and prolactin release: the effects of perturbing calcium on catalytic adenylate cyclase activity.
Schettini G; Hewlett EL; Cronin MJ; Koike K; Yasumoto T; MacLeod RM
Neuroendocrinology; 1986; 44(1):1-7. PubMed ID: 3024052
[TBL] [Abstract][Full Text] [Related]
9. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
Login IS; Judd AM; MacLeod RM
Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
12. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells.
Login IS; Kuan SI; Judd AM; MacLeod RM
Endocrinology; 1990 Oct; 127(4):1948-55. PubMed ID: 1698150
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
15. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Lamberts SW; van Koetsveld P; Verleun T
Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
[TBL] [Abstract][Full Text] [Related]
16. Role of calcium in dopaminergic regulation of TRH- and angiotensin II-stimulated prolactin release.
Login IS; Judd AM; Kuan SI; MacLeod RM
Am J Physiol; 1991 Apr; 260(4 Pt 1):E553-60. PubMed ID: 1902061
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
18. Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro.
Spangelo BL; Judd AM; Ross PC; Login IS; Jarvis WD; Badamchian M; Goldstein AL; MacLeod RM
Endocrinology; 1987 Dec; 121(6):2035-43. PubMed ID: 2824178
[TBL] [Abstract][Full Text] [Related]
19. Difference in calcium requirements for forskolin-induced release of prolactin from normal pituitary cells and GH4C1 cells in culture.
Delbeke D; Scammell JG; Dannies PS
Endocrinology; 1984 Apr; 114(4):1433-40. PubMed ID: 6323146
[TBL] [Abstract][Full Text] [Related]
20. Maitotoxin stimulates hormonal release and calcium flux in rat anterior pituitary cells in vitro.
Schettini G; Koike K; Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
Am J Physiol; 1984 Oct; 247(4 Pt 1):E520-5. PubMed ID: 6496670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
